Vitamin d Levels and Coronary Catheterization

decreased vitamin d levels are associated with increased inflammatory markers,and renin angiotensin levels.

decreased levels were also found to be connected to increased cardiovascular mortality.

we therefore hypothesise that in patients with pathological results of coronary catheterization we will find decreased levels of 25 hydroxy vitamin d.

we will examine patients undergoing elective coronary catheterization and compare two groups: those with normal results and those with pathological results.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vitamin D Deficiency Avitaminosis Deficiency Diseases Malnutrition Nutrition Disorders Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Assaf Harofeh Mc

Ẕerifin, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age

>18 years,
no known ihd

Exclusion criteria

renal failure ,
medications including vitamin d, calcium ,phosphate
hyper or hypoparathyroidism,
abnormal calcium or phosphate values,
known pathological coronary catheterization.

Sponsors and collaborators

Lead sponsor

Assaf-Harofeh Medical Center

Other Gov

Registry information

Official study title

25 Hydroxy Vitamin d Levels in Patients Undergoing an Elective Coronary Catheterization

Important dates

Study start: 2008
Primary completion: 2009
Study completion: 2009
First posted: Sep 9, 2008
Registry last updated: Dec 16, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed